The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...
Bristol Myers Squibb is doubling down on a partnership with Medidata, signing a multiyear agreement to continue using the ...
Bristol Myers Squibb (NYSE:BMY) said it expects to report a Q4 net expense of $18M related to acquired IPRD and licensing ...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has extended and expanded its partnership with Bristol Myers ...
Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb ...